Further study revealed that NETs promoted NSCLC metastasis by regulating lncRNA MIR503HG expression to facilitate NF‐κB/NLRP3 signalling pathway activation, and lncRNA MIR503HG and NLRP3 may be new targets for the treatment of NSCLC. Here, NFKB1 is linked to non-small cell lung carcinoma.